Stay up to date with the latest news from DCL.
Data Conversion Laboratory, Court Square Group, and JANA Life Sciences Launch Learning Series to Inform Technology and Intelligent Content Solutions to the Life Sciences Market
Improving the Clinical and Drug Development Life Cycle Through Content Structure, IT Systems, Compliance, and Program Management
Fresh Meadows, NY, November 19, 2020 – Data Conversion Laboratory (DCL), Court Square Group, and JANA Life Sciences announce a learning series for life sciences and biomedical research organizations to dive deep into content structure and cloud-based solutions for managing and safeguarding content in the life sciences. A series of webinars beginning December 10 and continuing into 2021 provide life science organizations with a rich understanding of technology considerations related to content and data.
Technology plays a critical role in the life sciences where accuracy, traceability, and compliance along with speed-to-market is critical. Improving content and data management, IT systems, compliance, and program management streamlines research, drug development, and the regulatory approval process. These leading technology firms have a deep history of content and data structure expertise, FDA 21 CFR Part11 compliant infrastructure and tools, and technical documentation capabilities that support success at every stage of the pharma and biomedical product life cycle.
“The goal of this webinar series is to inform life science organizations about technology considerations related to content and data,” explains Mark Gross, President of DCL. “Intelligent content solutions and cloud-based solutions applied to the drug development life cycle improve downstream communication and speed up the approval process, ultimately bringing scientific breakthroughs to market both quickly and safely.”
DCL provides content structure to documents that are critical to support the life sciences industry. With the latest advances in artificial intelligence and natural language processing, DCL’s content enrichment services improve content discovery for R&D applications during the development of new drugs or reclassification of pharma agents. Additionally, DCL’s structured product labeling (SPL) work comprises deconstructing forms-based content and image-based PDFs to create structured markup (XML). DCL creates and delivers final SPL files to the FDA on behalf of its clients.
Technology is critical to improving how the biomedical and pharma industries can increase business performance while also securing intellectual property. DCL, Court Square Group, and JANA Life Sciences provide technology solutions that support pharma and biotech companies and ensure regulatory compliance, ultimately bringing products to market faster. To learn more about the series and register for the first webinar, please visit www.dataconversionlaboratory.com/webinars.
About Data Conversion Laboratory
Data Conversion Laboratory (DCL) provides data and content transformation services and solutions. Using the latest innovations in artificial intelligence, including machine learning and natural language processing, DCL helps businesses organize and structure data and content for modern technologies and platforms. With expertise across many industries including publishing, life sciences, government, manufacturing, technology and professional organizations, DCL uses its advanced technology and U.S.-based project management teams to solve the most complex conversion challenges securely, accurately and on time. DCL is the industry leader in XML content conversion, DITA conversion, S1000D conversion, SPL conversion services, and so much more. Founded in 1981, DCL was named one of EContent's Top 100 Companies in the Digital Content Industry.
About Court Square Group
Court Square Group (CSG) (courtsquaregroup.com) is the leading provider of an Audit Ready Compliant Cloud™ (ARCC) platform for Life Science companies. The ARCC cloud platform and out-of-the-box tools provide a validated and cost-effective way to manage all digital content (EDMS/documents, voice, data and video) in a regulated and compliant environment. At every stage of development and manufacturing lifecycle, Court Square's cloud, collaboration and regulatory submission solutions reduce costs, complexity and risks associated with sharing, storing, and submitting information for regulatory requirements. With over 1,000+ submissions and twenty-five years' experience and a 95% client retention rate, CSG has a proven track record as one of the most cost-efficient solutions in the life sciences market.
About JANA Life Sciences
JANA Life Sciences (janalifesciences.com) is a division of JANA, Inc. (janacorp.com). As a third-generation, family-owned business, our technical services and solutions have been employed since 1973 by many of the nation’s largest and most successful high-tech companies. JANA Life Sciences was established to leverage the company’s proven Engineering and Technical Documentation expertise together with core competencies in Operational Excellence, Project & Program Management and IT Systems to the life sciences. Our focus is on healthcare services, pharmaceuticals, biotechnology (Biotech), medical research, medical devices (Medtech) and information technology.